AIMS: More than 90% of cases of renovascular disease (RVD) are caused by atherosclerosis; thus patients with this condition are at high risk for vascular events. We examined the association of statins with prognosis in patients with RVD. METHODS AND RESULTS: We performed a population-based cohort study in 4040 patients with RVD older than 65 years using province-wide health data in Ontario, Canada. The primary outcome was time to first cardiorenal event, specifically myocardial infarction, stroke, heart failure, acute renal failure, dialysis or death; the primary analysis used a time-dependent covariate for statin exposure. Despite having a greater burden of cardiovascular and renal comorbidity, the risk of the primary outcome was significantly lower in statin users than in non-users [unadjusted hazard ratio (HR) 0.51, 95% confidence interval (CI) 0.47-0.57; P < 0.0001]. This association was materially unchanged after adjusting for demographic characteristics, cardiovascular risk factors, other comorbidities, measures of health-care utilization, screening, and concomitant medications (adjusted HR 0.51, 95% CI 0.46-0.57). An analysis using the same endpoint in a propensity-matched cohort without time-dependent statin exposure revealed a lower risk of the primary outcome in statin-treated patients but with a substantially more conservative point estimate (HR 0.82, 95% CI 0.71-0.95). CONCLUSION: These data suggest that statins are associated with improved prognosis in elderly patients with RVD.
AIMS: More than 90% of cases of renovascular disease (RVD) are caused by atherosclerosis; thus patients with this condition are at high risk for vascular events. We examined the association of statins with prognosis in patients with RVD. METHODS AND RESULTS: We performed a population-based cohort study in 4040 patients with RVD older than 65 years using province-wide health data in Ontario, Canada. The primary outcome was time to first cardiorenal event, specifically myocardial infarction, stroke, heart failure, acute renal failure, dialysis or death; the primary analysis used a time-dependent covariate for statin exposure. Despite having a greater burden of cardiovascular and renal comorbidity, the risk of the primary outcome was significantly lower in statin users than in non-users [unadjusted hazard ratio (HR) 0.51, 95% confidence interval (CI) 0.47-0.57; P < 0.0001]. This association was materially unchanged after adjusting for demographic characteristics, cardiovascular risk factors, other comorbidities, measures of health-care utilization, screening, and concomitant medications (adjusted HR 0.51, 95% CI 0.46-0.57). An analysis using the same endpoint in a propensity-matched cohort without time-dependent statin exposure revealed a lower risk of the primary outcome in statin-treated patients but with a substantially more conservative point estimate (HR 0.82, 95% CI 0.71-0.95). CONCLUSION: These data suggest that statins are associated with improved prognosis in elderly patients with RVD.
Authors: Douglas S Lee; Linda Donovan; Peter C Austin; Yanyan Gong; Peter P Liu; Jean L Rouleau; Jack V Tu Journal: Med Care Date: 2005-02 Impact factor: 2.983
Authors: A Iaina; G Benyamin; O Levtov; R Getter; I Serban; Y Wollman; A Rubinstein; S Cabili; G Peer; M Blum Journal: Ren Fail Date: 1994 Impact factor: 2.606
Authors: Kimberley J Hansen; Matthew S Edwards; Timothy E Craven; Gregory S Cherr; Sharon A Jackson; Richard G Appel; Gregory L Burke; Richard H Dean Journal: J Vasc Surg Date: 2002-09 Impact factor: 4.268
Authors: David A Folt; Kaleigh L Evans; Sravya Brahmandam; Wencan He; Pamela S Brewster; Shipeng Yu; Timothy P Murphy; Donald E Cutlip; Lance D Dworkin; Kenneth Jamerson; William Henrich; Philip A Kalra; Sheldon Tobe; Ken Thomson; Andrew Holden; Brian L Rayner; Liliana Grinfeld; Steven T Haller; Christopher J Cooper Journal: J Am Soc Hypertens Date: 2015-03-28
Authors: Diana Vassallo; James Ritchie; Darren Green; Constantina Chrysochou; Joseph Blunt; Philip A Kalra Journal: BMC Nephrol Date: 2016-12-07 Impact factor: 2.388
Authors: Danijela Gnjidic; David G Le Couteur; Fiona M Blyth; Tom Travison; Kris Rogers; Vasi Naganathan; Robert G Cumming; Louise Waite; Markus J Seibel; David J Handelsman; Andrew J McLachlan; Sarah N Hilmer Journal: BMJ Open Date: 2013-03-09 Impact factor: 2.692